| A critical review of icosapent ethyl in cardiovascular risk reduction J Huston, H Schaffner, A Cox, A Sperry, S Mcgee, P Lor, L Langley, ... American Journal of Cardiovascular Drugs 23 (4), 393-406, 2023 | 7 | 2023 |
| A systematic review of cannabidiol based dosage forms AJ Sperry, T Youssef, Y Tuong, AS Chauhan Precis Nanomed 4 (4), 851-878, 2021 | 7 | 2021 |
| Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity AJ Sperry, J Hardy, RF Goldfaden, A Hurst, A Ashchi, D Sutton, ... Drugs of the Future 47 (6), 2022 | 1 | 2022 |
| Comparison of Vanco Ready® Vancomycin Injection Premix with Lyophilized Vancomycin Products in a Simulated Compounding & Clinical Setting AJ Sperry, J Cruikshank, H Hoang, K Nichols, GE MacKinnon III, ... Pharmaceutical Science and Technology 7 (1), 13-19, 2023 | | 2023 |
| Abelacimab. Anti-factor XI/XIa monoclonal antibody, Treatment of atrial fibrillation, Treatment of thrombotic disorders J Hardy, A Sperry, H Hartmann, R Goldfaden, M Ashchi, R Kim, J Huston, ... Drugs of the Future 46 (12), 2021 | | 2021 |
| Comparison of EMERPHED™(Ephedrine Sulfate) Injection with Current Concentrated Ephedrine Products in Simulated Clinical Settings AJ Sperry, J Cruikshank, A Winn, KJ MacKinnon, NZ Gerges, ... | | |
